265 related articles for article (PubMed ID: 33499170)
1. Extreme HOT regions are CpG-dense promoters in C. elegans and humans.
Chen RA; Stempor P; Down TA; Zeiser E; Feuer SK; Ahringer J
Genome Res; 2014 Jul; 24(7):1138-46. PubMed ID: 24653213
[TBL] [Abstract][Full Text] [Related]
2. The multi-omic landscape of transcription factor inactivation in cancer.
Teschendorff AE; Zheng SC; Feber A; Yang Z; Beck S; Widschwendter M
Genome Med; 2016 Aug; 8(1):89. PubMed ID: 27562343
[TBL] [Abstract][Full Text] [Related]
3. Characterization of H3K9me3 and DNA methylation co-marked CpG-rich regions during mouse development.
Yang H; Wang Y; Zhang Y
BMC Genomics; 2023 Nov; 24(1):663. PubMed ID: 37924034
[TBL] [Abstract][Full Text] [Related]
4. A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect.
Lopez-Serra P; Marcilla M; Villanueva A; Ramos-Fernandez A; Palau A; Leal L; Wahi JE; Setien-Baranda F; Szczesna K; Moutinho C; Martinez-Cardus A; Heyn H; Sandoval J; Puertas S; Vidal A; Sanjuan X; Martinez-Balibrea E; Viñals F; Perales JC; Bramsem JB; Ørntoft TF; Andersen CL; Tabernero J; McDermott U; Boxer MB; Vander Heiden MG; Albar JP; Esteller M
Nat Commun; 2014 Apr; 5():3608. PubMed ID: 24699711
[TBL] [Abstract][Full Text] [Related]
5. Transposable elements in normal and malignant hematopoiesis.
Lemerle E; Trompouki E
Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37503739
[TBL] [Abstract][Full Text] [Related]
6. The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers.
Zhang Q; Zhu Y; Cao X; Tan W; Yu J; Lu Y; Kang R; Wang X; Li E
Mol Cancer; 2023 Mar; 22(1):45. PubMed ID: 36882835
[TBL] [Abstract][Full Text] [Related]
7. LncRNA affects epigenetic reprogramming of porcine embryo development by regulating global epigenetic modification and the downstream gene
Zhang D; Zhou Y; Huang R; Zhai Y; Wu D; An X; Zhang S; Shi L; Li Q; Kong X; Yu H; Li Z
Front Physiol; 2022; 13():971965. PubMed ID: 36187791
[TBL] [Abstract][Full Text] [Related]
8. Association of DNA methylation with steroidogenic enzymes in Cushing's adenoma.
Kodama T; Oki K; Otagaki Y; Baba R; Okada A; Itcho K; Kobuke K; Nagano G; Ohno H; Hinata N; Arihiro K; Gomez-Sanchez CE; Yoneda M; Hattori N
Endocr Relat Cancer; 2022 Aug; 29(8):495-502. PubMed ID: 35675123
[TBL] [Abstract][Full Text] [Related]
9. IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Yang JR; Wang J; Li HM; Gao S; Fan YC; Wang K
Front Oncol; 2022; 12():746643. PubMed ID: 35359408
[TBL] [Abstract][Full Text] [Related]
10. Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?
Gimeno-Valiente F; López-Rodas G; Castillo J; Franco L
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158828
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
12. Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation.
Hughes AL; Kelley JR; Klose RJ
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194567. PubMed ID: 32360393
[TBL] [Abstract][Full Text] [Related]
13. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
14. The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer.
Zardo G
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499170
[TBL] [Abstract][Full Text] [Related]
15. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.
Skvortsova K; Masle-Farquhar E; Luu PL; Song JZ; Qu W; Zotenko E; Gould CM; Du Q; Peters TJ; Colino-Sanguino Y; Pidsley R; Nair SS; Khoury A; Smith GC; Miosge LA; Reed JH; Kench JG; Rubin MA; Horvath L; Bogdanovic O; Lim SM; Polo JM; Goodnow CC; Stirzaker C; Clark SJ
Cancer Cell; 2019 Feb; 35(2):297-314.e8. PubMed ID: 30753827
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
